Can a sleep pill help smokers kick the habit?

NCT ID NCT07328594

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether daridorexant, a recently FDA-approved sleep medication, can improve sleep quality and daytime alertness in smokers who struggle with insomnia during quit attempts. About 44 adult smokers who smoke at least 10 cigarettes daily will take the drug or a placebo for 3 weeks while trying to reduce or stop smoking. Researchers will monitor sleep patterns, alertness, and withdrawal symptoms to see if better sleep helps with quitting.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
daridorexant
What this could lead to
If successful, daridorexant could help smokers with insomnia sleep better and stay alert during quit attempts, potentially improving cessation rates.
What could go wrong
This is a small, early-phase trial with only 44 participants, so results may not apply widely. The drug may not improve smoking abstinence or could cause side effects like daytime drowsiness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Legacy Research Institute

    Portland, Oregon, 97232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.